migraine relief
Generic: acetaminophen, aspirin, caffeine
Labeler: kroger companyDrug Facts
Product Profile
Brand Name
migraine relief
Generic Name
acetaminophen, aspirin, caffeine
Labeler
kroger company
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
acetaminophen 250 mg/1, aspirin 250 mg/1, caffeine 65 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
30142-896
Product ID
30142-896_d97b47b3-44c2-44b2-a2c9-fec2e9dc3b17
Product Type
HUMAN OTC DRUG
Marketing Category
ANDA
Application Number
ANDA075794
Listing Expiration
2026-12-31
Marketing Start
2019-10-09
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
30142896
Hyphenated Format
30142-896
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
migraine relief (source: ndc)
Generic Name
acetaminophen, aspirin, caffeine (source: ndc)
Application Number
ANDA075794 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/1
- 65 mg/1
Packaging
- 1 BOTTLE in 1 CARTON (30142-896-62) / 24 TABLET, FILM COATED in 1 BOTTLE
- 1 BOTTLE in 1 CARTON (30142-896-78) / 100 TABLET, FILM COATED in 1 BOTTLE
Packages (2)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d97b47b3-44c2-44b2-a2c9-fec2e9dc3b17", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["de57809f-d5f8-41b3-84d4-b2ef54e0f6d7"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Kroger Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (30142-896-62) / 24 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "30142-896-62", "marketing_start_date": "20221025"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (30142-896-78) / 100 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "30142-896-78", "marketing_start_date": "20191009"}], "brand_name": "migraine relief", "product_id": "30142-896_d97b47b3-44c2-44b2-a2c9-fec2e9dc3b17", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "30142-896", "generic_name": "acetaminophen, aspirin, caffeine", "labeler_name": "Kroger Company", "product_type": "HUMAN OTC DRUG", "brand_name_base": "migraine relief", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "ANDA075794", "marketing_category": "ANDA", "marketing_start_date": "20191009", "listing_expiration_date": "20261231"}